Previous Close | 824.30 |
Open | 824.10 |
Bid | 809.20 x 0 |
Ask | 814.00 x 0 |
Day's Range | 801.95 - 829.00 |
52 Week Range | 317.00 - 850.05 |
Volume | |
Avg. Volume | 8,690 |
Market Cap | 35.078B |
Beta (5Y Monthly) | 1.17 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -136.75 |
Earnings Date | Feb 12, 2025 - Feb 17, 2025 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Aug 18, 2021 |
1y Target Est | 566.00 |
As global markets navigate the challenges posed by rising U.S. Treasury yields and tepid economic growth, investors are increasingly looking for opportunities in growth stocks, which have shown resilience amid broader market fluctuations. In this environment, companies with high insider ownership can be particularly appealing as they often signal strong confidence from those closest to the business's operations and future prospects.
Solara Active Pharma Sciences Ltd (BOM:541540) reports significant financial growth and strategic advancements despite ongoing challenges.